| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 53.039 | 64.130 | 60.487 | 98.503 | 102.546 | 223.998 | 733.824 | 701.845 | 755.521 |
| Total Income - EUR | - | 53.039 | 64.155 | 73.261 | 100.214 | 134.879 | 214.852 | 774.859 | 718.525 | 906.707 |
| Total Expenses - EUR | - | 49.955 | 62.595 | 51.512 | 84.489 | 123.455 | 113.422 | 592.010 | 665.038 | 825.538 |
| Gross Profit/Loss - EUR | - | 3.083 | 1.560 | 21.749 | 15.725 | 11.425 | 101.431 | 182.848 | 53.487 | 81.169 |
| Net Profit/Loss - EUR | - | 2.553 | 487 | 20.477 | 14.875 | 10.564 | 99.573 | 175.893 | 48.840 | 68.376 |
| Employees | - | 3 | 0 | 0 | 2 | 3 | 2 | 3 | 3 | 4 |
Check the financial reports for the company - Damad Biofarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 9.413 | 27.106 | 79.210 | 82.994 | 64.238 | 335.226 | 640.102 | 906.936 |
| Current Assets | - | 13.012 | 12.383 | 119.166 | 91.957 | 122.756 | 225.280 | 521.238 | 252.737 | 388.235 |
| Inventories | - | 9.833 | 605 | 16.978 | 23.492 | 40.739 | 16.518 | 64.762 | 64.239 | 260.748 |
| Receivables | - | 0 | 6.052 | 47.920 | 61.130 | 76.141 | 162.298 | 449.453 | 179.917 | 123.720 |
| Cash | - | 3.179 | 5.726 | 54.268 | 7.335 | 5.876 | 46.464 | 7.023 | 8.581 | 3.767 |
| Shareholders Funds | - | 2.598 | 3.040 | 23.484 | 38.552 | 47.884 | 146.395 | 178.712 | 169.170 | 236.601 |
| Social Capital | - | 45 | 44 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | 10.415 | 20.527 | 124.528 | 134.320 | 160.056 | 145.264 | 486.662 | 533.968 | 877.333 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 196.076 | 194.672 | 186.996 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Damad Biofarm Srl